Original news and analysis on international IP policy
On the side of this week’s World Intellectual Property Organization Standing Committee on Copyright and Related Rights (SCCR), the International Authors Forum held a side event on 7 December. Speakers underlined the importance of copyright for authors so that they can make a living from their writing, and warned about ill-defined fair use in copyright law.
The habit of patenting innovative products is being challenged by ever faster innovation cycles, the growing need for collaboration and co-invention, and what some classical patentees see as a “virus” of open source licensing. The tenth edition of the IP Summit, hosted in Berlin this year, heard some interesting stories from the smart home and smart car business.
European Trade Commissioner Cecilia Malmstroem, speaking to the President of the German Bundestag, Norbert Lammert, announced reading rooms for the consolidated texts of the Transatlantic Trade and Investment Partnership (TTIP) in all capitals of the EU member states.
CAPE TOWN, South Africa -- A law to regulate intellectual property derived from research and development conducted using public funds has boosted the number of patent applications filed and granted by universities and research institutions in the past five years.
The stretch run for Europe's Unitary Patent System (UPS) again took centre stage at the Premier Cercle IP Summit 2015 in Berlin yesterday. Eyes are on Germany for the ratification of the UPS. Cornelia Rudloff-Schäffer, president of the German Patent Office, in the keynote speech assured the 300 hundred participants Germany was preparing for the new system and called out to industry to prepare for the change, saying: “Check your portfolio now.”
Colombia has a decision to make. A full year has passed from the November 24, 2014 request by iFarma, Misión Salud and CIMUN for a declaration of the public interest regarding the cancer drug imatinib (marketed by Novartis as Gleevec/Glivec), the first step on the path toward a compulsory license in Colombia. Thus far, Colombia’s Ministry of Health and Social Protection has failed to act one way or another, leaving patients in limbo and the government at the mercy of a Swiss pharmaceutical giant that reported revenue of over $57.9 Billion USD in 2013, write James Love and Andrew S. Goldman.
For the first time in its history, the G10 Commission, an oversight body over the German Intelligence Services, will go to court to challenge decisions by the German government and the services, German Public Broadcasting and the Süddeutsche Zeitung revealed last night.
The African Regional Intellectual Property Organization (ARIPO) recently held two top organ meetings in Lusaka, Zambia, to debate the organisation’s strategic plan for 2016-2020.
Ten sites allegedly disrespectful to Kemal Attaturk, founder of modern Turkey, were enough for the courts in Turkey to ban a whole platform - YouTube - from 2008 until the end of 2010. But a ruling of the European Court of Human Rights today declared the blanket blocking a violation of the right to receive and impart information freely, protected under Article 10 of the European Convention on Human Rights.
Two bipartisan United States senators today released the results of an 18-month investigation into the US$84,000 price of the Sovaldi hepatitis C drug, finding the pricing and marketing strategy was aimed at maximizing revenue at the expense of access and affordability. The new report also shows the high impact on US government drug procurement programs and other data.
The Medicines Patent Pool has signed a collaborative agreement with the University of Liverpool to develop HIV nanomedicines.
Jonathan Band writes: During the negotiation of the Trans-Pacific Partnership Agreement, many concerns were voiced about how TPP would mandate adoption of US-style statutory damages. Under the US Copyright Act, a court can award damages of up to $30,000 per work infringed, which can be ratcheted up to $150,000 per work infringed in cases of willful infringement. Scholars have found that statutory damages in the US have discouraged investment in innovative technologies while incentivizing the emergence of copyright trolls. So how bad is the statutory damages provision in the final TPP agreement?